Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer R Ribeiro

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
JCO Precision Oncology|December 5, 2024
Genomic Landscape of Malignant Phyllodes Tumors Identifies Subsets for Targeted TherapyRani Bansal, Tolulope Adeyelu, Andrew Elliott, et al.
JCO Precision Oncology|September 7, 2023
Opposing Roles of <i>SPOP</i> Mutations in Human Prostate and Endometrial CancersLudimila Cavalcante, Sachin Kumar Deshmukh, Jennifer R Ribeiro, et al.
Frontiers in Pharmacology|April 4, 2019
Human Epididymis Secretory Protein 4 (HE4) Compromises Cytotoxic Mononuclear Cells via Inducing Dual Specificity Phosphatase 6Nicole E James, Matthew T Oliver, Jennifer R Ribeiro, et al.
Scientific Reports|May 24, 2020
The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genesNicole E James, Jenna B Emerson, Ashley D Borgstadt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 27, 2021
HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 ExpressionRachael B Rowswell-Turner, Rakesh K Singh, Anze Urh, et al.
Expert Review of Anticancer Therapy|April 16, 2025
Prevalence and molecular correlates of acquired <i>EGFR</i> resistance mutations in non-small cell lung cancer (NSCLC)Luis E Raez, Yasmine Baca, Jennifer R Ribeiro, et al.
British Journal of Cancer|September 3, 2024
Consensus molecular subtyping of metastatic colorectal cancer expands biomarker-directed therapeutic benefit for patients with CMS1 and CMS2 tumorsSaikat Chowdhury, Joanne Xiu, Jennifer R Ribeiro, et al.
NPJ Breast Cancer|December 20, 2025
Mechanisms of resistance to trastuzumab deruxtecan in breast cancer elucidated by multi-omic molecular profilingGeorge W Sledge, Joanne Xiu, Reshma L Mahtani, et al.
Cancer Immunology, Immunotherapy : CII|May 11, 2026
Broader gene representation by whole-exome sequencing improves accuracy of tumor mutational burden assessment for selection of pembrolizumab immunotherapyMilan Radovich, James Wacker, Jeffrey Solzak, et al.
JAMA Network Open|March 18, 2026
An AI Approach to Differentiating Lung Squamous Cell Carcinoma From Metastases of Other OriginsMark G Evans, Jennifer R Ribeiro, Todd Maney, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
JCO Precision Oncology|December 5, 2024
Genomic Landscape of Malignant Phyllodes Tumors Identifies Subsets for Targeted TherapyRani Bansal, Tolulope Adeyelu, Andrew Elliott, et al.
JCO Precision Oncology|September 7, 2023
Opposing Roles of <i>SPOP</i> Mutations in Human Prostate and Endometrial CancersLudimila Cavalcante, Sachin Kumar Deshmukh, Jennifer R Ribeiro, et al.
Frontiers in Pharmacology|April 4, 2019
Human Epididymis Secretory Protein 4 (HE4) Compromises Cytotoxic Mononuclear Cells via Inducing Dual Specificity Phosphatase 6Nicole E James, Matthew T Oliver, Jennifer R Ribeiro, et al.
Scientific Reports|May 24, 2020
The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genesNicole E James, Jenna B Emerson, Ashley D Borgstadt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 27, 2021
HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 ExpressionRachael B Rowswell-Turner, Rakesh K Singh, Anze Urh, et al.
Expert Review of Anticancer Therapy|April 16, 2025
Prevalence and molecular correlates of acquired <i>EGFR</i> resistance mutations in non-small cell lung cancer (NSCLC)Luis E Raez, Yasmine Baca, Jennifer R Ribeiro, et al.
British Journal of Cancer|September 3, 2024
Consensus molecular subtyping of metastatic colorectal cancer expands biomarker-directed therapeutic benefit for patients with CMS1 and CMS2 tumorsSaikat Chowdhury, Joanne Xiu, Jennifer R Ribeiro, et al.
NPJ Breast Cancer|December 20, 2025
Mechanisms of resistance to trastuzumab deruxtecan in breast cancer elucidated by multi-omic molecular profilingGeorge W Sledge, Joanne Xiu, Reshma L Mahtani, et al.
Cancer Immunology, Immunotherapy : CII|May 11, 2026
Broader gene representation by whole-exome sequencing improves accuracy of tumor mutational burden assessment for selection of pembrolizumab immunotherapyMilan Radovich, James Wacker, Jeffrey Solzak, et al.
JAMA Network Open|March 18, 2026
An AI Approach to Differentiating Lung Squamous Cell Carcinoma From Metastases of Other OriginsMark G Evans, Jennifer R Ribeiro, Todd Maney, et al.
Pageof 4